Study of CM336 in Relapsed or Refractory Multiple Myeloma Patients

Clinical trial NCT07181239 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07181239
Sponsor: Keymed Biosciences Co.Ltd
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Myeloma (MM)

Start date: 2025-09-01
Primary completion: 2027-09-01
Enrollment: 280

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.